Company Filing History:
1 out of 1,746 
1 out of 92 Years Active: 1992-2016
Title: Patrick Dansette: Innovator in Pharmaceutical Research
Introduction
Patrick Dansette is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative compounds and proteins. With a total of 2 patents, Dansette's work focuses on advancing medical treatments and therapies.
Latest Patents
Dansette's latest patents include groundbreaking inventions such as mutant cytochrome P450 2B6 proteins and their applications. This invention relates to mutant human cytochrome P450 2B6 (CYP2B6) proteins and fusion proteins that include these mutant proteins. The invention is particularly relevant for cancer treatment, utilizing virus-directed enzyme prodrug therapy. Another significant patent involves 1,2-dithiol-3-thion-S-oxide compounds and pharmaceutical compositions. This patent describes the use of 5-phenyl-3H-1,2-dithiol-3-thion-S-oxides as active substances in hepato-protective medicaments, highlighting new compounds that are substituted in the phenyl ring.
Career Highlights
Throughout his career, Patrick Dansette has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and Kali-Chemie Pharma GmbH. His experience in these institutions has allowed him to contribute to significant advancements in medical research and drug development.
Collaborations
Dansette has collaborated with notable colleagues, including Isabelle De Waziers and Walid Touati. These partnerships have further enriched his research and innovation efforts.
Conclusion
Patrick Dansette's contributions to pharmaceutical research and his innovative patents demonstrate his commitment to advancing medical science. His work continues to impact the field positively, paving the way for new treatments and therapies.